- Home
- MOLN vs KRMD Comparison
MOLN vs KRMD Comparison
Compare MOLN & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MOLN | KRMD |
|---|---|---|
| Founded | 2004 | 1980 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 158.9M | 198.3M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MOLN | KRMD |
|---|---|---|
| Price | $4.59 | $4.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $8.38 | $6.50 |
| AVG Volume (30 Days) | 4.1K | ★ 171.0K |
| Earning Date | 03-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | $318.52 | $17.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $3.36 | $1.87 |
| 52 Week High | $5.36 | $6.61 |
Technical Indicators
Market Signals| Indicator | MOLN | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 48.15 | 31.07 |
| Support Level | $3.51 | $3.80 |
| Resistance Level | $4.63 | $4.34 |
| Average True Range (ATR) | 0.27 | 0.22 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 40.09 | 9.30 |
Price Performance
Historical ComparisonAbout MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).